Brian E. Dixon - Concepedia

Author

Brian E. Dixon

Also Known As

B Dixon, B E Dixon, B. E. Dixon, B.E. Dixon, BRIAN DIXON, Bernard Dixon, Brian Dixon, Brian E Dixon, Brian E. Dixon, Brian Edward Dixon

434

Publications

6.9K

Citations

H-Index

151

Concepts

All Affiliations

Regenstrief Institute Indiana University – Purdue University Indianapolis Indiana University School of Medicine Health Services Research & Development Veterans Health Administration

About

Brian E. Dixon is an author at Regenstrief Institute specializing in public health, medicine, and health informatics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	6	6	130
2	Business	5	5	209
3	Health Sciences	3	3	49
4	Management	2	2	47
5	Language Studies	1	1	12

Brian E. Dixon

122

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings Mark G. Thompson, Edward Stenehjem, Shaun J. Grannis, New England Journal of Medicine	2021	490
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 Jill M. Ferdinands, Suchitra Rao, Brian E. Dixon, MMWR Morbidity and Mortality Weekly Report	2022	466
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 Mark G. Thompson, Karthik Natarajan, Stephanie A. Irving, MMWR Morbidity and Mortality Weekly Report	2022	427
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020 Nir Menachemi, Constantin T. Yiannoutsos, Brian E. Dixon, MMWR Morbidity and Mortality Weekly Report Indiana ResidentsVirus EpidemiologyPopulation Health SciencesDisease OutbreakCovid-19 Epidemiology	2020	198
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study Jill M. Ferdinands, Suchitra Rao, Brian E. Dixon, BMJ	2022	194
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 Nicola P. Klein, Melissa S. Stockwell, Maria Demarco, MMWR Morbidity and Mortality Weekly Report	2022	192
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 Peter J. Embí, Matthew E. Levy, Allison L. Naleway, MMWR Morbidity and Mortality Weekly Report	2021	188
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 Ruth Link‐Gelles, Matthew E. Levy, Manjusha Gaglani, MMWR Morbidity and Mortality Weekly Report	2022	124
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021 Catherine H. Bozio, Shaun J. Grannis, Allison L. Naleway, MMWR Morbidity and Mortality Weekly Report	2021	105
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023 Ruth Link‐Gelles, Zachary A. Weber, Sarah E. Reese, MMWR Morbidity and Mortality Weekly Report ImmunodeficienciesImmunologyAdvisory CommitteeVaccine HesitancyCovid-19	2023	96

Page 1